宫颈HPV状态与外阴、阴道及肛管高级别上皮内瘤变和癌风险:人群前瞻性队列研究
该研究基于丹麦40,399名宫颈癌筛查女性的液基细胞学样本,检测高危HPV并随访至15年,评估宫颈HPV状态与外阴、阴道及肛管高级别上皮内瘤变或癌(VIN2+、VaIN2+、AIN2+)的关联。结果显示宫颈HPV16感染与VIN2+、VaIN2+和AIN2+风险升高相关,其他高危型与VaIN2+风险升高相关。
要点
- 宫颈HPV16感染者发生VIN2+、VaIN2+和AIN2+的风险均显著高于HC2阴性女性。
- 其他高危HPV型别与VaIN2+风险升高相关,AIN2+风险呈边缘显著升高。
- 宫颈HPV16感染者10年累积VIN2+、VaIN2+、AIN2+发生率均较低(≤0.3%)。
核心结论
- 宫颈HPV16感染与外阴、阴道及肛管高级别上皮内瘤变或癌风险升高相关。
研究设计与样本
- 前瞻性队列研究纳入2002-2005年丹麦哥本哈根40,399名宫颈癌筛查女性的液基细胞学样本。
- 采用Hybrid Capture 2检测高危HPV,INNO-LiPA进行基因分型,并链接全国登记系统随访至15年。
主要发现
- 与HC2阴性女性相比,宫颈HPV16感染者VIN2+风险HR=2.6(95%CI 1.2-5.5),VaIN2+风险HR=23.5(95%CI 6.8-81.6),AIN2+风险HR=3.7(95%CI 1.1-12.2)。
- 其他高危HPV型别感染者VaIN2+风险HR=7.1(95%CI 2.3-22.3),AIN2+风险HR=2.2(95%CI 0.9-4.9)。
- 宫颈HPV16感染者10年累积VIN2+发生率为0.3%(95%CI 0.2%-0.7%),VaIN2+为0.2%(95%CI 0.1%-0.5%),AIN2+为0.1%(95%CI 0.0%-0.4%)。
临床怎么用
- 对宫颈HPV16阳性女性,除宫颈随访外应关注外阴、阴道及肛管病变风险。
- 其他高危HPV型别阳性女性亦需警惕阴道高级别病变可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: All cervical cancers and some vulvar, vaginal and anal cancers are caused by high-risk human papillomavirus (hrHPV). However, little is known about the association between cervical HPV infection and subsequent intraepithelial neoplasia and cancer at other anogenital sites. In this prospective cohort study, we estimated the risk of vulvar, vaginal and anal intraepithelial neoplasia grade 2/3 or cancer (VIN2+, VaIN2+, AIN2+) according to cervical hrHPV status. METHODS: Liquid-based cervical cytology samples were collected from 40,399 women screened against cervical cancer in Copenhagen, Denmark, during 2002-2005. Samples were tested for hrHPV using Hybrid Capture 2 (HC2) and genotyped using INNO-LiPA. We linked the cohort with Danish nationwide registries to identify cases of VIN2+, VaIN2+ and AIN2+ during up to 15 years of follow-up. We estimated age-adjusted hazard ratios (HRs) using Cox regression and cumulative incidences using Aalen-Johansen's estimator. RESULTS: Women with cervical HPV16 infection had increased hazard of VIN2+ (HR = 2.6; 95% confidence interval [CI], 1.2-5.5), VaIN2+ (HR = 23.5; 95% CI, 6.8-81.6) and AIN2+ (HR = 3.7; 95% CI, 1.1-12.2) compared with HC2 negative women. Women with other hrHPV types than HPV16 also had increased hazard of VaIN2+ (HR = 7.1; 95% CI, 2.3-22.3) and a borderline statistically significantly increased risk of AIN2+ (HR = 2.2; 95% CI, 0.9-4.9) compared with HC2 negative women. The 10-year cumulative incidences of VIN2+, VaIN2+ and AIN2+ in women with cervical HPV16 were 0.3% (95% CI, 0.2%-0.7%), 0.2% (95% CI, 0.1%-0.5%) and 0.1% (95 CI, 0.0%-0.4%). CONCLUSIONS: Cervical HPV16 infection is associated with increased risk of VIN2+, VaIN2+ and AIN2+.
引用
- Bertoli HK, Thomsen LT, Iftner T, et al. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study. Gynecol Oncol. 2020. PMID: 32008794. doi:10.1016/j.ygyno.2020.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。